Loss of OPTN, a monogenic cause of ALS, leads to RIPK1-dependent microglial activation, dysmyelination and necroptosis of motor neurons in the spinal cords of OPTN-/- mice, which was rescued by genetic and pharmacological inactivation of RIPK1 kinase (77). The gene discussed is RIPK1; the disease is amyotrophic lateral sclerosis.